These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28121231)

  • 21. Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis.
    Wongsaroj P; Udomchaisakul P; Tepsumethanon S; Khawplod P; Tantawichien T
    Vaccine; 2013 Mar; 31(13):1748-51. PubMed ID: 23370149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen.
    Ambrozaitis A; Laiskonis A; Balciuniene L; Banzhoff A; Malerczyk C
    Vaccine; 2006 May; 24(19):4116-21. PubMed ID: 16545510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the immunogenicity and safety of the purified chick embryo cell rabies vaccine manufactured in India and Germany: A randomized, single blind, multicentre, phase IV clinical study.
    Sampath G; Banzhoff A; Deshpande A; Malerczyk C; Arora AK; Vakil H; Preiss S
    Hum Vaccin Immunother; 2017 Jul; 13(7):1531-1538. PubMed ID: 28406752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity and Safety of a Purified Vero Rabies Vaccine-Serum Free, Compared With 2 Licensed Vaccines, in a Simulated Rabies Post-Exposure Regimen in Healthy Adults in France: A Randomized, Controlled, Phase 3 Trial.
    Pineda-Peña AC; Jiang Q; Petit C; Korejwo-Peyramond J; Donazzolo Y; Latreille M; Homery MC; Babin V; Benamor S; Pichon S; Guinet-Morlot F; Minutello AM
    Clin Infect Dis; 2024 Jun; 78(6):1748-1756. PubMed ID: 38478634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zagreb regimen, an abbreviated intramuscular schedule for rabies vaccination.
    Ren J; Yao L; Sun J; Gong Z
    Clin Vaccine Immunol; 2015 Jan; 22(1):1-5. PubMed ID: 25392012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and immunogenicity of two freeze-dried Vero cell rabies vaccines for human use in post-exposure prophylaxis.
    Wang LY; Sun MP; Zhang XC; Suo LD; Xu RH; Zou YJ; Zuo LB; Qi H
    Vaccine; 2011 Mar; 29(15):2679-81. PubMed ID: 21296694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protecting Indian schoolchildren against rabies: pre-exposure vaccination with purified chick embryo cell vaccine (PCECV) or purified verocell rabies vaccine (PVRV).
    Shanbag P; Shah N; Kulkarni M; Juvekar M; Madhusudana SN; Vakil HB; Malerczyk C
    Hum Vaccin; 2008; 4(5):365-9. PubMed ID: 18398307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and Immunogenicity of purified chick embryo cell rabies vaccine (VaxiRab N) administered intradermally as post exposure prophylaxis.
    Ravish HS; Vijayashankar V; Madhusudana SN; Sudarshan MK; Narayana DH; Andanaiah G; Ashwin BY; Rachana AR; Shamanna M
    Hum Vaccin Immunother; 2014; 10(8):2433-7. PubMed ID: 25424951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistence of rabies antibody 5 years after postexposure prophylaxis with vero cell antirabies vaccine and antibody response to a single booster dose.
    Zhang X; Zhu Z; Wang C
    Clin Vaccine Immunol; 2011 Sep; 18(9):1477-9. PubMed ID: 21752947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunological Effect of aGV Rabies Vaccine Administered Using the Essen and Zagreb Regimens: A Double-Blind, Randomized Clinical Trial.
    Miao L; Shi L; Yang Y; Yan K; Sun H; Mo Z; Li L
    Viral Immunol; 2018 Apr; 31(3):242-248. PubMed ID: 29394147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A serum-free, purified vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab for pre-exposure use in healthy adults: results from a randomized controlled phase-II trial.
    Pichon S; Guinet-Morlot F; Minutello M; Donazzolo Y; Rouzier R; Chassard D; Fitoussi S; Hou V
    Vaccine; 2013 Apr; 31(18):2295-301. PubMed ID: 23510665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Comparative Study on the Adverse Reactions of Purified Chick Embryo Cell Vaccine (PCECV) and Purified Vero Cell Rabies Vaccine (PVRV).
    Ramezankhani R; Shirzadi MR; Ramezankhani A; Poor Mozafary J
    Arch Iran Med; 2016 Jul; 19(7):502-7. PubMed ID: 27362245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized, blind, controlled phase III clinical trial: Assessing the immunogenicity and safety of freeze-dried human rabies vaccine (vero cell) with a 4-dose regimen (2-1-1) in a 10-60 year-old demographic.
    Jin F; Zhu L; Wang Y; Qin G; Tian Y; Xie Y; Jin H; Zhang Y; Wang L; Li J; Wu Z; Sheng Y; Shi L; Yang G; Zhao Z; Chen L; Chen P; Jiang Z; Yu J; Gao Z; Li Q; Wu X; Miao L
    Vaccine; 2024 Oct; 42(23):126059. PubMed ID: 38937182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and immunogenicity of rabies vaccine as 4 - dose Essen Intramuscular regimen for post exposure prophylaxis: A non - randomized, comparative controlled study.
    Haradanahalli RS; Banerjee R; Kalappa MS; Narayana A; Annadani RR; Bilagumba G
    Hum Vaccin Immunother; 2021 Aug; 17(8):2554-2559. PubMed ID: 33621471
    [No Abstract]   [Full Text] [Related]  

  • 35. A phase II randomized study to determine the safety and immunogenicity of the novel PIKA rabies vaccine containing the PIKA adjuvant using an accelerated regimen.
    Kalimuddin S; Wijaya L; Chan YFZ; Wong AWL; Oh HML; Wang LF; Kassim JA; Zhao J; Shi Z; Low JG
    Vaccine; 2017 Dec; 35(51):7127-7132. PubMed ID: 29174316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen.
    Madhusudana SN; Sanjay TV; Mahendra BJ; Suja MS
    Int J Infect Dis; 2004 May; 8(3):175-9. PubMed ID: 15109593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and immunogenicity of a new purified vero cell rabies vaccine (PVRV) administered by intramuscular and intradermal routes in healthy volunteers.
    Kulkarni PS; Sapru A; D'costa PM; Pandit A; Madhusudana SN; Yajaman AB; Mangrule S; Gunale B; Bavdekar AR
    Vaccine; 2013 May; 31(24):2719-22. PubMed ID: 23583817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of post-exposure rabies prophylaxis during pregnancy: a follow-up study from Guangzhou, China.
    Huang G; Liu H; Cao Q; Liu B; Pan H; Fu C
    Hum Vaccin Immunother; 2013 Jan; 9(1):177-83. PubMed ID: 23442589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preventing rabies with the Verorab vaccine: 1985-2005 Twenty years of clinical experience.
    Toovey S
    Travel Med Infect Dis; 2007 Nov; 5(6):327-48. PubMed ID: 17983973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized non-inferiority clinical study to assess post-exposure prophylaxis by a new purified vero cell rabies vaccine (Rabivax-S) administered by intramuscular and intradermal routes.
    Bose A; Munshi R; Tripathy RM; Madhusudana SN; Harish BR; Thaker S; Mahendra BJ; Gunale B; Gogtay NJ; Thatte UM; Mani RS; Manjunath K; George K; Yajaman AB; Sahai A; Dhere RM; Alex RG; Adhikari DD; Abhilash ; Raghava V; Kumbhar D; Behera TR; Kulkarni PS
    Vaccine; 2016 Sep; 34(40):4820-6. PubMed ID: 27554534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.